Pancreatic Cancer Research

ResearcherAffiliated Hospital of Nantong UniversityActive in the last 2 years

Pengcheng Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7030-0525; OpenAlex author ID A5101742556. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 2 papers

Papers 3

  1. Age and sex-dependent tumor microbiome programs shape pancreatic cancer prognosis. Co-author DOI 10.1016/j.isci.2026.116542↗
  2. TRIM29 may facilitate progression of pancreatic ductal adenocarcinoma through immune remodeling. Co-author DOI 10.1016/j.pan.2026.10.006↗
  3. Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer. Co-author DOI 10.1038/s41392-024-01872-7↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuaiwu Luo · 2 shared papers, 2026 · strength 0.53
  2. Jun Yang · 2 shared papers, 2026 · strength 0.53
  3. Yewei Zhang · 1 shared paper, 2024 · strength 0.28
  4. Yonghao Xu · 1 shared paper, 2026 · strength 0.28
  5. Linquan Wu · 1 shared paper, 2026 · strength 0.28
  6. Enliang Li · 1 shared paper, 2026 · strength 0.25
  7. Long‐Yun Ye · 1 shared paper, 2026 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.